195 related articles for article (PubMed ID: 34661075)
1. Inhibition of Arginine Methylation Impairs Platelet Function.
Marsden AJ; Riley DRJ; Barry A; Khalil JS; Guinn BA; Kemp NT; Rivero F; Beltran-Alvarez P
ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1567-1577. PubMed ID: 34661075
[TBL] [Abstract][Full Text] [Related]
2. Peptidic transition state analogues as PRMT inhibitors.
Zhang Y; van Haren MJ; Martin NI
Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies.
Wang SM; Dowhan DH; Muscat GEO
J Mol Endocrinol; 2019 Apr; 62(3):R223-R237. PubMed ID: 30620710
[TBL] [Abstract][Full Text] [Related]
4. A patent review of arginine methyltransferase inhibitors (2010-2018).
Li X; Wang C; Jiang H; Luo C
Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
[TBL] [Abstract][Full Text] [Related]
5. Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system.
Barry A; Samuel SF; Hosni I; Moursi A; Feugere L; Sennett CJ; Deepak S; Achawal S; Rajaraman C; Iles A; Wollenberg Valero KC; Scott IS; Green V; Stead LF; Greenman J; Wade MA; Beltran-Alvarez P
Lab Chip; 2023 May; 23(11):2664-2682. PubMed ID: 37191188
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells.
Szewczyk MM; Vu V; Barsyte-Lovejoy D
J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424246
[TBL] [Abstract][Full Text] [Related]
7. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
Hu H; Qian K; Ho MC; Zheng YG
Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
[TBL] [Abstract][Full Text] [Related]
8. Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.
Bryant JP; Heiss J; Banasavadi-Siddegowda YK
Cells; 2021 Jan; 10(1):. PubMed ID: 33440687
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous ablation of prmt-1 and prmt-5 abolishes asymmetric and symmetric arginine dimethylations in Caenorhabditis elegans.
Hirota K; Shigekawa C; Araoi S; Sha L; Inagawa T; Kanou A; Kako K; Daitoku H; Fukamizu A
J Biochem; 2017 Jun; 161(6):521-527. PubMed ID: 28158808
[TBL] [Abstract][Full Text] [Related]
10. Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach.
Bhattacharya D; Shi Ming Li A; Paul B; Ghosh Dastidar U; Santhakumar V; Sarkar D; Chau I; Li F; Ghosh T; Vedadi M; Talukdar A
Eur J Med Chem; 2023 Nov; 260():115713. PubMed ID: 37597437
[TBL] [Abstract][Full Text] [Related]
11. Functional Study of
Lorenzon L; Quilles JC; Campagnaro GD; Azevedo Orsine L; Almeida L; Veras F; Miserani Magalhães RD; Alcoforado Diniz J; Rodrigues Ferreira T; Kaysel Cruz A
ACS Infect Dis; 2022 Mar; 8(3):516-532. PubMed ID: 35226477
[TBL] [Abstract][Full Text] [Related]
12. Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues.
Noto PB; Sikorski TW; Zappacosta F; Wagner CD; Montes de Oca R; Szapacs ME; Annan RS; Liu Y; McHugh CF; Mohammad HP; Piccoli SP; Creasy CL
Sci Rep; 2020 Dec; 10(1):22155. PubMed ID: 33335114
[TBL] [Abstract][Full Text] [Related]
13. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
[TBL] [Abstract][Full Text] [Related]
14. Scintillation proximity assay of arginine methylation.
Wu J; Xie N; Feng Y; Zheng YG
J Biomol Screen; 2012 Feb; 17(2):237-44. PubMed ID: 21821785
[TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferase biology in humans during acute and chronic skeletal muscle plasticity.
vanLieshout TL; Bonafiglia JT; Gurd BJ; Ljubicic V
J Appl Physiol (1985); 2019 Sep; 127(3):867-880. PubMed ID: 31369333
[TBL] [Abstract][Full Text] [Related]
16. The C. elegans PRMT-3 possesses a type III protein arginine methyltransferase activity.
Takahashi Y; Daitoku H; Yokoyama A; Nakayama K; Kim JD; Fukamizu A
J Recept Signal Transduct Res; 2011 Apr; 31(2):168-72. PubMed ID: 21385054
[TBL] [Abstract][Full Text] [Related]
17. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
[TBL] [Abstract][Full Text] [Related]
18. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
[TBL] [Abstract][Full Text] [Related]
19. Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies.
Sauter C; Simonet J; Guidez F; Dumétier B; Pernon B; Callanan M; Bastie JN; Aucagne R; Delva L
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358861
[TBL] [Abstract][Full Text] [Related]
20. Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).
Morales Y; Cáceres T; May K; Hevel JM
Arch Biochem Biophys; 2016 Jan; 590():138-152. PubMed ID: 26612103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
